Videos
March 4, 2024 | Daily JAM, PYPL, Top 50 Stocks, Videos |
Today’s Quick Pick is Stripe. Stripe isn’t public yet but will likely go public in late 2024 or in 2025. This is an alert to prepare for this IPO. Stripe started in 2011 and is the “Paypal of its time.” I use both platforms and I find Stripe the more powerful and more user-friendly payment platform. Stripe recently did a private, series H deal that valued the company at $65 billion. Paypal, its major competitor (along with Square), has a market cap of $65 billion. I think this will be a very hot, oversubscribed IPO share you can make a quick profit by flipping the shares on IPO day. The recent Series H offer means that Stripe probably won’t go public until the last half of 2024, at the earliest, or more likely 2025. Which give you time to get your ducks in a row in order to put in a bid for some shares in the offering. Talk to your broker now to ensure you sign all the right paperwork and meet eligibility requirements for IPO offers. If you get that started now, you’ll be able to place an order for IPO shares when they’re available. Stripe revenue is at $14 billion with about 19% of the market share versus 42% for PaylPal. The company has just turned EBITDA profitable, a major milestone. This is an appealing IPO and something to start preparing for even though it may be a little ways down the road.
February 29, 2024 | Daily JAM, Jubak Picks, Videos, Volatility |
Today’s Hot Button Moves NOW video is Buy Viking Therapeutics (VKTX). Last week I suggested that you buy GLP-1 drug stocks like Eli Lilly (LLY) or Novo Nordisk (NVO). This class of diabetes and weight loss drugs is growing rapidly, with $36.5 billion in sales in 2023. Viking Therapeutics, a development-stage biotech company, recently announced Phase 2 trial results for its compound VK2735. This drug has the potential to be the best in its class when it hits the market. The company still has to go through Phase 3 trials and approval, but the data show VK2735 to be more effective at weight loss than its competitors. It could also be one of the few drugs of its kind to be available orally. The current round of trials shows that the drug will need to be injected less frequently than competitors. The company trades with a market cap of $9 billion (in contrast to Lilly’s $720 billion market cap) and is still small enough that it could be bought before the expensive process of taking a drug to market. (Although the company recently raised a secondary offering that would advance marketing plans.) I would buy this up to $100 a share and expect it to continue to zoom as more good news, I expect, on the oral version gets released this quarter. I am adding the stock to my online portfolios today, Thursday, February 29. You can find a write up on this pick on my subscription JubakAM.com and free JubakPicks.com sites.
February 22, 2024 | Daily JAM, Videos |
Today’s video is Doldrums from now through April.. Doldrums are, “a state or period of inactivity, stagnation, or depression” or, in nautical terms, the places where tradewinds converged and ships were left stagnant on the ocean until a storm or the wind picked up to get the vessel back in motion. The recent stock plunge of 26% from Palo Alto Networks (PANW) certainly doesn’t feel like a market that is stagnant or waiting for a change in the winds, but I think that’s what we’ll see going forward. After Nvidia’s report, there aren’t any big earnings reports expected until April and we’ll likely be moving sideways until the Fed sets the market sailing with a rate cut. The odds of the Fed not doing anything at the March meeting according to the CME Fedwatch are up to 90%. That rate cut expectation has now moved solidly to June or July with the CME Fedwatch polling at 75% for June and 90% for June or July. Until those rate cuts happen, and with little to no market-moving earnings reports expected in the months between, the stock market will be drifting in the doldrums while we wait for the wind to pick up.
February 20, 2024 | Daily JAM, Jubak Picks, LLY, Videos |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
February 16, 2024 | Daily JAM, Dividend Income, Videos |
Today’s Quick Pick is Cheniere Energy (LNG). Cheniere is a liquified gas supplier and the stock was down about 7.5-8% this year. Much of that drop was a reaction to the Biden administration’s decision to delay permits for new LNG export facilities in order to put pressure on the industry to decrease their methane emissions. However, this is essentially a non-issue for Cheniere since the company’s most recent expansion had already been permitted. The company is on track to go from a capital-intensive/debt heavy stage to putting billions into new sites and export facilities to a generator of free cash flow from those completed facilities. The current dividend is only 1.05% but the total yield, (dividends plus stock buybacks) is about 6.05%. Management has said they believe there will be enough free cash flow to raise the dividend rate by 10% a year from now until the mid to late 20s. In my opinion, demand for LNG is shifting as markets like Japan and China are transitioning to nuclear or solar and wind, but there is still growing demand from places like India, which is looking to transition away from coal. Cheniere is predicting 3% annual revenue growth and I think that’s reasonable and enough to keep the cash flow and dividends moving. I will be Cheniere to my Dividend Portfolio on those future yield prospects.
February 15, 2024 | Daily JAM, Mid Term, Videos |
Today’s video is Inflation: Stickier for Longer. The market is now beginning to suspect that the Fed has a last mile problem. The CPI numbers from Tuesday weren’t terrible, but they weren’t as low as the market hoped. Headline inflation was at 3.1% annual rate and core inflation was 3.9%–markedly better than the past high of 9%, but not quite hitting the 2.9% for headline inflation that economists were looking for. The miss has finished a flip in sentiment about a March rate cut. The CME FedWatch poll in January had March rate cut odds at 90% likely, now, just a month later, the odds of no action are up to nearly 90%. Only about a third of investors believe there will be a rate cut in May with odds of no action up to 61%. The calendar is being pushed out to June or July for cuts from the Fed. This has resulted in bond yields going back up, around 4.3% on the ten year Treasury, and stocks going down a bit. There is a hope out there that the CPI numbers were a January blip, but if you look at the breakdown of the inflation numbers, it seems clear that inflation is just plain sticky. The Atlanta Federal Reserve Bank index that looks at the sectors that tend to be sticky and how much they’re influencing the overall inflation rate shows that prices in those sticky inflation categories have stopped and that they are a major factor keeping inflation higher than hoped. . Additionally, while there’s been a big drop in goods prices, the price of services has not gone down nearly as much. The super core inflicts number, which looks a prices in the services sector after taking out the cost of shelter has stalled. All this to say, we’ve got good evidence that this last mile from 3% to 2% on inflation could take a while.
February 12, 2024 | Daily JAM, KRE, Videos, Volatility |
I’m adding a bit more timeliness to this weekly video slot by moving away from my Trend of the Week series and changing it to “Hot Button Moves NOW” to highlight action you can take now.. Today’s Hot Button Moves NOW video is: Put Options on the S&P Regional Banking ETF (KRE). This is a play on continued trouble in the regional banking sector. New York Community Bank has just been downgraded to junk by Moody’s, (due to its real estate loan portfolio) and has dropped by 60%, taking the regional bank sector along with it. Last Monday I bought puts for April 24 at 14 strike price for $2.09 each and the put price has gone through the February 7 date when I recorded this video. I don’t think this is the end of regional bank trouble so I’ll be holding on to these puts until the bad news subsides. This is a good way to take advantage of some of these dips in the market and hedge risks. For more options and volatility stocks, subscribe to JubakAM.com.
February 10, 2024 | CVS, Daily JAM, Dividend Income, Videos |
Today’s Quick Pick is CVS Health (CVS). CVS owns a unique combination of healthcare delivery channels. Drugstores, yes–9,000 of them. But the company also owns health insurance company, Aetna, and Caremark, the largest pharmacy benefit manager. And recently it moved into the primary care marketplace through its acquisition of Oak Street. The company reported earnings on Wednesday, February 7, and the stock was up about 3.25% after that. While the earnings were good, (they beat by $0.13) the guidance is what is important here. The company projected higher costs for 2024 and cut guidance for GAAP earnings ($7.06) and adjusted earnings ($8.30). The reason the stock went up despite these cuts is that everyone was expecting DEEPER cuts to guidance. CVS has been signaling for weeks that rising costs in 2024 could be painful for the healthcare sector as a whole, and the relatively minor cuts in guidance led to a rally in the stock. Morningstar calculates a fair value for CVS Health of $103 a share. The stock closed at $76.32 on February 9. The stock also pays a 2.36% dividend. The stock is a member of my Dividend Portfolio. That position is up 31.25% since October 28, 2020.
February 8, 2024 | Daily JAM, Short Term, Videos |
Today’s video is A Battle Between Fear and Greed. As the S&P gets closer to 5,000, we clearly see the battle between fear and greed. With the market breaking records on the high end, there’s a fear that it’ll crash, and that it has to go down eventually. However, the greed side is a fear of missing out on this rally that started in September as well as a likely market boost from a rate cut in May. So how do you play this mix? My thought is to go with the greed side for now, but not be too greedy. Be aware that investors aren’t likely to get out of stocks in a big way until they see the projected gains from a Fed rate cut. At worst the market may move sideways until then, and some consolidation in the market leaders would be good, so I wouldn’t do much selling just yet.
February 5, 2024 | Daily JAM, Short Term, Videos |
Today’s Trend of the Week is How Long Does FOMO Drive this Market? FOMO is “fear of missing out” and I’m using it to describe a market that is not driven by facts and fundamentals, but is largely focused on a fear of missing out on another rally, as many did in 2023. So what is the emotional trend and how long will it last? My sense is that there is one factor determining behind a lot of FOMO is expectations for a rate cut from the Fed. A potential rate cut could bring a lot more money into the market and drive prices higher– something investors don’t want to miss. In my opinion, we’ll have to wait until May or Jun for that cut to happen. So the hope of a cut will keep the market moving sideways and limit selling on high valuations. We’ll see some consolidation in the market leaders, but nothing that is likely to upend the market before these highly anticipated rate cuts.
February 2, 2024 | Daily JAM, Dividend Income, Videos |
Today’s Quick Pick is Hasbro (HAS). This stock isn’t terribly exciting or groundbreaking. There’s no big new tech connected to this pick. Hasbro makes toys and traditional toys are considered a declining industry. The stock is indeed ,60% off of its 2019 high. This is not a growth stock, but it is a reliable, high yield, dividend stock. Cash flow from toy sales is consistent enough to keep the 5.5-6% coming Sales may be flat this year but licensing with brands like My Little Pony and Transformers keep the company’s toys top of mind with kids and in the media. Hasbro is one of three major toy brands that make up 40% of the traditional U.S. toy market and 30% of the global market. The industry may not be exciting, but the high dividend yield makes this worth a look. I’ll be adding this to my Jubak Picks Dividend Portfolio next week.
February 1, 2024 | Daily JAM, Jubak Picks, MSFT, Top 50 Stocks, Videos |
Today’s video is Microsoft Shows Priced to Perfection Risks. This quarter, the company reported Tuesday, Azure, its cloud services flagship, grew revenue by 30% last year. While a 30% growth rate would be a great for many companies, Wall Street and analysts were disappointed in this news from Microsoft. This is the “priced to perfection” problem. Although the company beat earnings estimates, beat revenue estimates, and showed 30% growth in a key part of the company, the stock went down. Maybe a $3 trillion market cap on Microsoft is a lot of weight to push up hill. We could see more of this during this earnings season as Amazon, Apple and Meta release their own reports. The “Magnificent Seven” that were responsible for most of the 24% gain in the S&P in 2023 are beginning to wobble. My hope was for more market leaders to emerge but that doesn’t seem to be happening. I don’t expect “wobble” to cause anything that terrible in the market, but a sideways move is likely as investors ponder their next move.
